English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Purpose To develop and evaluate a tool for the qualitative prediction of human oral bioavailability (F human ) from animal oral bioavailability (F animal ) data employing ROC analysis and to identify the optimal thresholds for such predictions. Methods A dataset of 184 compounds with known F human  and F animal  in at least one species (mouse, rat, dog and non-human primates (NHP)) was employed. A binary classification model for F human  was built by setting a threshold for high/low F human  at 50%. The thresholds for high/low F animal  were varied from 0 to 100 to generate the ROC curves. Optimal thresholds were derived from ‘cost analysis’ and the outcomes with respect to false negative and false positive predictions were analyzed against the BDDCS class distributions. Results We successfully built ROC curves for the combined dataset and per individual species. Optimal F animal  thresholds were found to be 67% (mouse), 22% (rat), 58% (dog), 35% (NHP) and 47% (combined dataset). No significant trends were observed when sub-categorizing the outcomes by the BDDCS. Conclusions F animal  can predict high/low F human  with adequate sensitivity and specificity. This methodology and associated thresholds can be employed as part of decisions related to planning necessary studies during development of new drug candidates and lead selection.

The Use of ROC Analysis for the Qualitative Prediction of Human Oral Bioavailability from Animal Data